Nick Norwitz Has Total Cholesterol of 700 — So Why Zero Plaque? – TFP #030 | Nick Norwitz MD PhD

In this episode of The Feldman Protocol, can living with an LDL of 700 for seven years actually leave your arteries plaque-free? Nick Norwitz (MD PhD) makes the case that the conventional cholesterol narrative is far more complicated than mainstream medicine admits, while Dave and Nick also cover the paternalistic medical system, statin side effects in women, Nick's surprising decision to take a cholesterol-lowering drug, and the recent Peter Attia rebuttal to lean mass hypersponder research.---🔥 This episode is sponsored by us --Own Your Labs 👉 `https://ownyourlabs.com/sp/30` Private blood testing services🩸Over 300 blood tests💰Extremely affordable❤️ We love our customers(Yes, we are literally funding the entire podcast from our own company -- so if you want to show your support, keep getting your private blood testing through our service. Thank you! 🙏)---🔗 CONNECT WITH DAVE FELDMAN:Main Channel: `https://youtube.com/@realDaveFeldman`X/Twitter: `https://x.com/realDaveFeldman`Instagram: `https://instagram.com/realDaveFeldman`Website: `https://thefeldmanprotocol.com`---⏱ Chapters3:03 – Who is Nick Norwitz?3:51 – Leaving medicine's conventional path5:52 – The calling Dave never felt8:23 – Science communication as medicine's future10:30 – Empowering patients with information11:24 – Statins lower GLP-1: the hidden data13:10 – Death knell of paternalistic medicine16:19 – Dave's origin: The Feldman Protocol18:31 – Why "we don't know" comforts patients21:43 – Nick's illness, misdiagnosis & obsession24:04 – The podcast origin story & echo disaster28:41 – Cholesterol Code film blowing up31:19 – Balancing science and accessibility in film36:06 – Peter Attia's rebuttal to LMHR research38:18 – Who's willing to have an open conversation?41:01 – Causality vs. importance in lipid science44:17 – Over-medicating metabolically healthy people47:01 – Statins harm women more: the X chromosome mechanism50:45 – The nocebo effect as gaslighting55:03 – Dave's blinded crossover statin experiment57:04 – Plot twist: Nick is taking a cholesterol drug59:05 – Ezetimibe and Alzheimer's disease1:02:01 – Plot twist 2: why Nick chose ezetimibe1:04:00 – Plot twist 3: the 7-year coronary CT angiography1:08:19 – Nick's CAD score at year 2 & family risk1:14:10 – Clinical experience vs. contending with data1:23:33 – Is Nick anti-statin? Dave presses hard1:27:34 – Bempedoic acid & PPAR alpha activation1:32:39 – Peter Attia's article vs. the LMHR team1:36:24 – How to find Nick Norwitz everywhere---#FeldmanProtocol #DaveFeldman #NickNorwitz #LDLCholesterol #LeanMassHypersponder #CholesterolCode #StatinSideEffects #Ezetimibe #HeartHealth #LipidResearch #MetabolicHealth #Atherosclerosis #PatientEmpowerment #ScienceCommunication #Bempedoicacid #AlzheimersResearch #CardiovascularHealth #LowCarb #KetogenicDiet